Apogee Therapeutics, Inc.

Delisted

CIK 1974640fmd_11PDVX58GM64PD4W8PV93X3K49Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Apr 01, 2022 to Jun 30, 2026, 16 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).